The Point of View of Hematological Cancer Patients and Their Loved Ones Regarding Spirituality

NCT04412135 | Unknown

• 1 other identifier: 87RI19_0050
• Study Type: observational
• Target: 10
• Locations: 0 countries
• Sites: N/A

Brief Summary

The management of patients with malignant hemopathy is based on comprehensive management. In this context and faced with the various difficulties encountered by cancer patients, the question of spirituality and its experience is central. Spirituality refers to the person's attachment to what inspires and gives him foundation, as well as the beliefs, values, and existential experiences associated with it, whether these are religious in nature or not. Although the concept has been identified as a resource in the literature and widely treated in an end-of-life context, assessing the needs of patients with hematological cancer and their loved ones in terms of spirituality from the initiation of treatment does not has not been developed

Conditions

Hematologic Cancer

Outcome Measures

Primary Outcomes (1)

• FACIT-Sp questionnaire

  15 minutes

Interventions

spirituality OTHER

Patients will take three questionnaires (FACIT-Sp, Euroqol 5 dimensions and ESAS)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

hematologic cancer patient and family member

You may qualify if:

• Aged ≥ 18 years with a recent diagnosis of hematological cancer (lymphoma or leukemia) and in treatment;
• Patients who speak and read French;
• Patients in general condition (physical and mental) judged emotionally and physically fit by the referring nurse to answer the questionnaires;
• Patients benefiting from a social security scheme,
• Patients who signed the non-objection form after being informed of the study,
• family person:
• Have been designated by the patient as being the loved one they wish to include with them;
• Aged ≥ 18 years;
• Fluent in and reading French;
• Having signed the non-objection form after being informed of the study.

You may not qualify if:

• Patients in recurrence / progress or in remission of cancer;
• Patients in the terminal phase of the disease.
• Family person:
• person in the curative phase of cancer

Sponsors & Collaborators

• University Hospital, Limoges: lead

MeSH Terms

Conditions

Hematologic Neoplasms

Interventions

Spiritual Therapies

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Hematologic Diseases; Hemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Complementary Therapies; Therapeutics

Central Study Contacts

Jean TONIOLO

CONTACT

+33 5 55 05 67 55; jean.toniolo@chu-limoges.fr

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: May 29, 2020
• First Posted: June 2, 2020
• Study Start: June 1, 2020
• Primary Completion: February 1, 2021
• Study Completion: June 1, 2021
• Last Updated: June 2, 2020

Record last verified: 2020-03

Data Sharing

• IPD Sharing: Will not share